These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26926587)

  • 21. Effect of a keto acid-amino acid supplement on the metabolism and renal elimination of branched-chain amino acids in patients with chronic renal insufficiency on a low protein diet.
    Teplan V; Schück O; Horácková M; Skibová J; Holecek M
    Wien Klin Wochenschr; 2000 Oct; 112(20):876-81. PubMed ID: 11244613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: an open-label prospective trial.
    Wu MT; Tung SC; Hsu KT; Lee CT
    J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):271-7. PubMed ID: 23223162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body composition of patients on a very low-protein diet: a two-year survey with DEXA.
    Chauveau P; Vendrely B; El Haggan W; Barthe N; Rigalleau V; Combe C; Aparicio M
    J Ren Nutr; 2003 Oct; 13(4):282-7. PubMed ID: 14566765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influence of protein and phosphorous restricted diet supplemented with essential aminoacids (EAA) and their alpha-keto-analogues (KAA) on nutritional status of children with chronic renal failure (CRF)].
    Trajković-Pavlović Lj; Popović-Rolović M; Dimitrijević D; Jovanović O; Antić-Peco A; Cvorkov-Drazić M; Radić J; Kruscić D; Kostić M
    Srp Arh Celok Lek; 1994; 122(7-8):193-6. PubMed ID: 17974383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role for ketoacid supplements in the management of CKD?
    Shah AP; Kalantar-Zadeh K; Kopple JD
    Am J Kidney Dis; 2015 May; 65(5):659-73. PubMed ID: 25682182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influential factors on serum albumin concentration in hospitalized chronic kidney disease patients.
    Yoshimoto S; Nagai K; Shibata E; Ueda S; Ono H; Tamaki M; Nishimura K; Obata F; Inagaki T; Minato M; Kishi F; Matsuura M; Matsui N; Endo I; Hann M; Kishi S; Murakami T; Abe H; Doi T
    J Med Invest; 2017; 64(1.2):146-152. PubMed ID: 28373613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension.
    Fujisaki K; Tsuruya K; Nakano T; Taniguchi M; Higashi H; Katafuchi R; Kanai H; Nakayama M; Hirakata H; Kitazono T;
    Hypertens Res; 2014 Nov; 37(11):993-8. PubMed ID: 24965167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease.
    Garneata L; Mircescu G
    J Ren Nutr; 2013 May; 23(3):210-3. PubMed ID: 23611549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure.
    Meloni C; Tatangelo P; Cipriani S; Rossi V; Suraci C; Tozzo C; Rossini B; Cecilia A; Di Franco D; Straccialano E; Casciani CU
    J Ren Nutr; 2004 Oct; 14(4):208-13. PubMed ID: 15483780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success.
    Hirsch S; Hirsch J; Bhatt U; Rovin BH
    Am J Nephrol; 2012; 36(5):430-7. PubMed ID: 23128144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
    Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM;
    Am J Kidney Dis; 2015 Jan; 65(1):49-57. PubMed ID: 25115616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progression of renal function in patients with chronic kidney disease on a low-protein diet supplemented with aminoacids and ketoanalogues].
    Aimar MA; Pomiglio G; Baccaro F; Traverso M; Audisio J; De Feo P; Crivelli A; Flores Lazdin M
    Nutr Hosp; 2018 Apr; 35(3):655-660. PubMed ID: 29974776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
    Drüeke TB; Locatelli F; Clyne N; Eckardt KU; Macdougall IC; Tsakiris D; Burger HU; Scherhag A;
    N Engl J Med; 2006 Nov; 355(20):2071-84. PubMed ID: 17108342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a supplemented hypoproteic diet in chronic kidney disease.
    Mircescu G; Gârneaţă L; Stancu SH; Căpuşă C
    J Ren Nutr; 2007 May; 17(3):179-88. PubMed ID: 17462550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
    Skali H; Lin J; Pfeffer MA; Chen CY; Cooper ME; McMurray JJ; Nissenson AR; Remuzzi G; Rossert J; Parfrey PS; Scott-Douglas NW; Singh AK; Toto R; Uno H; Ivanovich P
    Am J Kidney Dis; 2013 Feb; 61(2):238-46. PubMed ID: 23159232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional status in stage V dialyzed patient versus CKD patient on conservative therapy across different economic status.
    Vijayan M; Abraham G; Alex ME; Vijayshree N; Reddy Y; Fernando E; Mathew M; Nair S; Yuvaraj A
    Ren Fail; 2014 Apr; 36(3):384-9. PubMed ID: 24456000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A practical approach to low protein diets for patients with chronic kidney disease in Cameroon.
    Ashuntantang GE; Fouda H; Kaze FF; Halle MP; Tabi-Arrey C; Biwole-Sida M
    BMC Nephrol; 2016 Sep; 17(1):126. PubMed ID: 27605112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical relevance of anemia treatment in patients with chronic kidney disease].
    Vuksanović-Mikulicić S; Mikolasević I; Jelić I; Bubić I; Sladoje-Martinović B; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):193-202. PubMed ID: 23441533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.